Corbus Pharmaceuticals Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical Cancers
Go back to Corbus Pharmaceuticals Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical Cancers| (NASDAQ: CRBP) | Delayed: 8.46 +0.15 (1.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.31 | 52 Week High | $10.78 | |||
| Open | $8.17 | 52 Week Low | $1.01 | |||
| Day High | $8.68 | P/E | N/A | |||
| Day Low | $8.05 | EPS | $0.00 | |||
| Volume | 272,879 | |||||
